Compound Detail
CHEMBL865
VALDECOXIB 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL865 |
| Name | VALDECOXIB |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | LNPDTQAFDNKSHK-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
39
Targets
205
Activities
2
Assay Types
0
PK Parameters
20
Publications
6
Known Names
8
Indications
1
Mechanisms
Molecular Properties
314.4
MW (Da)
2.96
ALogP
4
HBA
1
HBD
86.2
PSA (Ų)
0.80
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2001 |
| Availability | Withdrawn |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Cyclooxygenase-2 inhibitor | INHIBITOR | Prostaglandin G/H synthase 2 | ✓ | ✓ |
Indications
Arthritis, Rheumatoid Dysmenorrhea Osteoarthritis Rheumatic Diseases Pain Pharyngitis Osteoarthritis, Knee Pancreatitis
ATC Classification
M01AH03
valdecoxib
Level 1: MUSCULO-SKELETAL SYSTEM
Level 2: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
Drug Warnings
Withdrawn
neurotoxicity
Risk for heart attack and stroke
Withdrawn
dermatological toxicity
associated with increased risk of serious cardiovascular events and an increased risk of serious skin reactions (e.g., toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme) compar...
Withdrawn
cardiotoxicity
Cardiovascular risk, (heart attack or stroke)
Withdrawn
cardiotoxicity
Cardiovascular risk, (heart attack or stroke)
Withdrawn
cardiotoxicity
Increased risk of heart attack
Withdrawn
cardiotoxicity
Risk for heart attack and stroke
Withdrawn
dermatological toxicity
associated with increased risk of serious cardiovascular events and an increased risk of serious skin reactions (e.g., toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme) compar...
Withdrawn
cardiotoxicity
associated with increased risk of serious cardiovascular events and an increased risk of serious skin reactions (e.g., toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme) compar...
Withdrawn
dermatological toxicity
Serious skin reactions and cardiovascular problems
Withdrawn
dermatological toxicity
associated with increased risk of serious cardiovascular events and an increased risk of serious skin reactions (e.g., toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme) compar...
Activity Summary
Ki 167 meas. best 8.28
IC50 38 meas. best 8.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Prostaglandin G/H synthase 2 CHEMBL230 | IC50 | 8.3 | 7.5271 | 5.0 | 14 |
| Unchecked CHEMBL612545 | Ki | 8.28 | 6.2288 | 5.3 | 41 |
| Carbonate dehydratase CHEMBL3745586 | Ki | 8.28 | 8.28 | 5.3 | 1 |
| Carbonic anhydrase 12 CHEMBL3242 | Ki | 7.89 | 7.89 | 13.0 | 5 |
| Carbonic anhydrase 9 CHEMBL3594 | Ki | 7.57 | 7.195 | 27.0 | 8 |
| Carbonic anhydrase 9 CHEMBL3594 | IC50 | 7.57 | 7.57 | 27.0 | 1 |
| Alpha carbonic anhydrase CHEMBL1075028 | Ki | 7.54 | 7.54 | 28.7 | 2 |
| Carbonic anhydrase 2 CHEMBL205 | IC50 | 7.37 | 6.6933 | 43.0 | 3 |
| Carbonic anhydrase 2 CHEMBL205 | Ki | 7.37 | 7.295 | 43.0 | 40 |
| Carbonic anhydrase 15 CHEMBL5973 | Ki | 7.18 | 7.18 | 66.0 | 1 |
| Carbonic anhydrase 5B, mitochondrial CHEMBL3969 | Ki | 7.06 | 7.06 | 88.0 | 1 |
| Carbonic anhydrase CHEMBL6185 | Ki | 7.01 | 7.01 | 97.0 | 1 |
| Carbonic anhydrase 14 CHEMBL3510 | Ki | 6.97 | 6.97 | 107.0 | 1 |
| Carbonic anhydrase CHEMBL3932 | Ki | 6.89 | 6.755 | 130.0 | 2 |
| AGAP002992-PA CHEMBL3399914 | Ki | 6.79 | 6.79 | 164.0 | 1 |
| Carbonic anhydrase 4 CHEMBL281 | IC50 | 6.47 | 6.47 | 340.0 | 2 |
| Carbonic anhydrase 4 CHEMBL281 | Ki | 6.47 | 6.47 | 340.0 | 2 |
| Carbonic anhydrase 4 CHEMBL3729 | Ki | 6.47 | 6.07 | 340.0 | 3 |
| Delta carbonic anhydrase CHEMBL3097982 | Ki | 6.42 | 6.42 | 378.0 | 1 |
| Carbonic anhydrase 13 CHEMBL2186 | Ki | 6.37 | 6.37 | 425.0 | 1 |
| Carbonic anhydrase 13 CHEMBL3912 | Ki | 6.37 | 6.37 | 425.0 | 1 |
| Astrosclerin-3 CHEMBL1944499 | Ki | 6.29 | 6.29 | 517.0 | 1 |
| Carbonic anhydrase, alpha family CHEMBL3621035 | Ki | 6.28 | 6.28 | 529.0 | 1 |
| Carbonic anhydrase 6 CHEMBL3025 | Ki | 6.24 | 6.24 | 572.0 | 2 |
| Carbonic anhydrase CHEMBL5931 | Ki | 6.18 | 6.18 | 654.0 | 1 |
| Carbonic anhydrase 2 CHEMBL6068 | Ki | 6.17 | 6.17 | 682.0 | 2 |
| Carbonic anhydrase CHEMBL5337 | Ki | 6.16 | 6.16 | 699.0 | 2 |
| Carbonic anhydrase 2 CHEMBL1697676 | Ki | 6.15 | 6.15 | 704.0 | 1 |
| Homo sapiens CHEMBL372 | IC50 | 6.05 | 5.32 | 890.0 | 4 |
| Carbonic anhydrase 5A, mitochondrial CHEMBL4789 | Ki | 6.04 | 6.04 | 912.0 | 1 |
| Blood CHEMBL613416 | IC50 | 5.96 | 5.96 | 1100.0 | 1 |
| Cytochrome c oxidase subunit 2 CHEMBL6174 | IC50 | 5.96 | 5.96 | 1100.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | Ki | 5.54 | 5.54 | 2903.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | IC50 | 5.53 | 5.53 | 2927.0 | 1 |
| Carbonic anhydrase 7 CHEMBL2326 | Ki | 5.41 | 5.41 | 3900.0 | 4 |
| Carbonic anhydrase CHEMBL1649055 | Ki | 5.24 | 5.24 | 5710.0 | 1 |
| PROBABLE TRANSMEMBRANE CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) CHEMBL5767 | Ki | 5.11 | 5.11 | 7810.0 | 1 |
| Beta-carbonic anhydrase 1 CHEMBL5631 | Ki | 4.89 | 4.89 | 12970.0 | 2 |
| Prostaglandin G/H synthase 1 CHEMBL221 | IC50 | 4.57 | 4.515 | 27000.0 | 2 |
| Carbonic anhydrase 1 CHEMBL261 | Ki | 4.27 | 4.27 | 54000.0 | 32 |
| Carbonic anhydrase 1 CHEMBL261 | IC50 | 4.27 | 4.27 | 54000.0 | 2 |
| Carbonic anhydrase CHEMBL3926 | Ki | 4.21 | 4.21 | 61000.0 | 1 |
| Carbonic anhydrase 3 CHEMBL2885 | Ki | 4.11 | 4.11 | 78000.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 4.06 | 4.06 | 88000.0 | 1 |
| Cytochrome c oxidase subunit 1 CHEMBL6011 | IC50 | 4.02 | 4.02 | 96200.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine